Hombre Seguro (Safe Men): a sexual risk reduction intervention for male clients of female sex workers

BMC Public Health. 2014 May 20:14:475. doi: 10.1186/1471-2458-14-475.

Abstract

Background: Male clients of female sex workers (FSWs) are at risk of HIV and other sexually transmitted infections (STIs). We conducted a two-arm randomized controlled trial to test the efficacy of a sexual risk reduction intervention for male clients of FSWs in Tijuana, Mexico.

Methods/design: Male clients of FSWs who were at least 18, were HIV-negative at baseline, and reported recent unprotected sex with FSWs were randomized to the Hombre Seguro sexual risk reduction intervention, or a time-attention didactic control condition. Each condition lasted approximately one hour. Participants underwent interviewer-administered surveys and testing for HIV and other STIs at baseline, and at 4, 8, and 12 month follow-ups. Combined HIV/STI incidence and unprotected vaginal and anal sex acts with FSWs were the primary outcomes.

Discussion: A total of 400 participants were randomized to one of the two conditions. Analyses indicated that randomization was successful; there were no significant differences between the participants in the two conditions at baseline. Average follow-up was 84% across both conditions. This is the first study to test the efficacy of a sexual risk reduction intervention for male clients of FSWs using the rigor of a randomized controlled trial.

Trial registration: NCT01280838, Date of registration: January 19, 2011.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Behavior Therapy*
  • Female
  • HIV Infections / etiology
  • HIV Infections / prevention & control*
  • HIV Infections / transmission
  • Humans
  • Incidence
  • Male
  • Mexico
  • Middle Aged
  • Motivational Interviewing*
  • Risk Reduction Behavior*
  • Safe Sex*
  • Sex Work*
  • Sex Workers
  • Sexual Behavior
  • Sexually Transmitted Diseases
  • Unsafe Sex*
  • Young Adult

Associated data

  • ClinicalTrials.gov/NCT01280838